Director Jon Kuwahara resigns from Emmaus Life Sciences board

Emmaus Life Sciences, Inc.

Director Jon Kuwahara resigned from the board of Emmaus Life Sciences on April 13, 2026, effective April 15, 2026.
Willis Lee remains Chairman and Chief Executive Officer of Emmaus Life Sciences.
Emmaus Life Sciences has no securities registered under Section 12(b) of the Exchange Act and no trading symbol.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.